Il y a eu 50 transactions d'initiés récentes enregistrées pour Geron Corporation (GERN), dont 35 achats et 9 ventes. Le total des achats d'initiés s'élève à $22.27M et le total des ventes d'initiés à $20.31M.
Les initiés notables ayant une activité récente comprennent Spiegel Robert J., Andrews Patricia S, Chinoporos Constantine. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — GERN
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-31 |
Spiegel Robert J. |
Director |
Attribution de RSU |
5,243 |
$1.49 |
$7.81K |
199,707 |
| 2026-03-25 |
Andrews Patricia S |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-03-25 |
Andrews Patricia S |
Director |
Attribution de RSU |
270,000 |
$1.57 |
$423.9K |
270,000 |
| 2026-03-25 |
Chinoporos Constantine |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-03-25 |
Chinoporos Constantine |
Director |
Attribution de RSU |
270,000 |
$1.57 |
$423.9K |
270,000 |
| 2026-02-18 |
Robertson Michelle |
EVP, Chief Financial Officer |
Vente Informative |
9,855 |
$1.94 |
$19.12K |
17,645 |
| 2026-02-17 |
Robertson Michelle |
EVP, Chief Financial Officer |
Attribution de RSU |
1,660,000 |
$1.80 |
$2.99M |
1,660,000 |
| 2026-02-17 |
Eid Joseph |
EVP, R&d; Chief Medical Office |
Attribution de RSU |
2,220,000 |
$1.80 |
$4M |
2,220,000 |
| 2025-12-31 |
Spiegel Robert J. |
Director |
Attribution de RSU |
5,918 |
$1.32 |
$7.81K |
194,464 |
| 2025-10-20 |
Elnawawi Ahmed |
EVP, Chief Commercial Officer |
Inconnu |
- |
- |
- |
10,000 |
| 2025-10-20 |
Elnawawi Ahmed |
EVP, Chief Commercial Officer |
Attribution de RSU |
3,000,000 |
$1.27 |
$3.81M |
3,000,000 |
| 2025-09-30 |
Spiegel Robert J. |
Director |
Attribution de RSU |
5,702 |
$1.37 |
$7.81K |
188,546 |
| 2025-08-07 |
Semerjian Harout |
President and CEO |
Inconnu |
- |
- |
- |
- |
| 2025-08-07 |
Semerjian Harout |
President and CEO |
Attribution de RSU |
4,000,000 |
$1.30 |
$5.2M |
4,000,000 |
| 2025-06-30 |
Spiegel Robert J. |
Director |
Attribution de RSU |
5,540 |
$1.41 |
$7.81K |
182,844 |
| 2025-05-21 |
Lawlis V Bryan |
Director |
Attribution de RSU |
180,000 |
$1.34 |
$241.2K |
180,000 |
| 2025-05-21 |
Spiegel Robert J. |
Director |
Attribution de RSU |
180,000 |
$1.34 |
$241.2K |
180,000 |
| 2025-05-21 |
Aggarwal Gaurav |
Director |
Attribution de RSU |
180,000 |
$1.34 |
$241.2K |
180,000 |
| 2025-05-21 |
Molineaux Susan |
Director |
Attribution de RSU |
180,000 |
$1.34 |
$241.2K |
180,000 |
| 2025-05-21 |
Bir Dawn Carter |
Interim President and CEO |
Attribution de RSU |
180,000 |
$1.34 |
$241.2K |
180,000 |
| 2025-05-21 |
O'farrell Elizabeth G. |
Director |
Attribution de RSU |
180,000 |
$1.34 |
$241.2K |
180,000 |
| 2025-05-21 |
Mcdonald John F |
Director |
Attribution de RSU |
180,000 |
$1.34 |
$241.2K |
180,000 |
| 2025-05-09 |
Lawlis V Bryan |
Director |
Achat Informatif |
13,300 |
$1.18 |
$15.67K |
13,300 |
| 2025-03-31 |
Spiegel Robert J. |
Director |
Attribution de RSU |
4,913 |
$1.59 |
$7.81K |
177,304 |
| 2025-02-27 |
Scarlett John A |
Chairman, President and CEO |
Achat Informatif |
12,500 |
$1.77 |
$22.06K |
12,500 |
| 2025-02-27 |
Samuels Scott Alan |
EVP, Chief Legal Officer |
Achat Informatif |
15,000 |
$1.61 |
$24.15K |
26,682 |
| 2025-02-27 |
Ziegler James |
EVP, Chief Commercial Officer |
Achat Informatif |
100,000 |
$1.60 |
$160K |
100,000 |
| 2025-02-18 |
Grethlein Andrew J |
EVP, Chief Operating Officer |
Attribution de RSU |
140,000 |
- |
- |
140,000 |
| 2025-02-18 |
Scarlett John A |
Chairman, President and CEO |
Attribution de RSU |
410,000 |
- |
- |
410,000 |
| 2025-02-18 |
Robertson Michelle |
EVP, Chief Financial Officer |
Attribution de RSU |
110,000 |
- |
- |
110,000 |
| 2025-02-18 |
Samuels Scott Alan |
EVP, Chief Legal Officer |
Attribution de RSU |
104,000 |
- |
- |
104,000 |
| 2025-02-18 |
Ziegler James |
EVP, Chief Commercial Officer |
Attribution de RSU |
89,000 |
- |
- |
89,000 |
| 2024-12-31 |
Spiegel Robert J. |
Director |
Retour de RSU |
2,206 |
- |
- |
172,391 |
| 2024-12-31 |
Spiegel Robert J. |
Director |
Attribution de RSU |
2,206 |
$3.54 |
$7.81K |
172,391 |
| 2024-11-11 |
Eid Joseph |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-11-11 |
Eid Joseph |
EVP, Research and Development |
Retour de RSU |
2,500,000 |
$4.12 |
$10.3M |
2,500,000 |
| 2024-09-30 |
Spiegel Robert J. |
Director |
Retour de RSU |
1,767 |
- |
- |
170,185 |
| 2024-09-30 |
Spiegel Robert J. |
Director |
Attribution de RSU |
1,767 |
$4.54 |
$8.02K |
170,185 |
| 2024-09-09 |
Ziegler James |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-09-09 |
Ziegler James |
EVP, Chief Commercial Officer |
Retour de RSU |
1,600,000 |
$4.41 |
$7.06M |
1,600,000 |
| 2024-07-08 |
Grethlein Andrew J |
EVP, Chief Operating Officer |
Exercice d'Options (Vente) |
452,804 |
$1.72 |
$778.82K |
- |
| 2024-06-28 |
Spiegel Robert J. |
Director |
Attribution de RSU |
1,916 |
$4.24 |
$8.12K |
168,418 |
| 2024-06-28 |
Spiegel Robert J. |
Director |
Retour de RSU |
1,916 |
- |
- |
168,418 |
| 2024-06-10 |
Kapur Anil |
EVP, Corp Strategy & Cco |
Vente Informative |
421,875 |
$4.65 |
$1.96M |
- |
| 2024-06-10 |
Feller Faye |
EVP, Chief Medical Officer |
Exercice d'Options (Vente) |
155,400 |
$1.30 |
$201.24K |
- |
| 2024-06-06 |
Grethlein Andrew J |
EVP, Chief Operating Officer |
Attribution de RSU |
452,804 |
$1.72 |
$778.82K |
452,804 |
| 2024-06-06 |
Scarlett John A |
Chairman, President and CEO |
Attribution de RSU |
1,000,000 |
$1.72 |
$1.72M |
1,000,000 |
| 2024-06-06 |
Kapur Anil |
EVP, Corp Strategy & Cco |
Attribution de RSU |
250,000 |
$1.43 |
$357.5K |
250,000 |
| 2024-06-06 |
Robertson Michelle |
EVP, Chief Financial Officer |
Attribution de RSU |
250,000 |
$2.17 |
$542.5K |
250,000 |
| 2024-06-06 |
Feller Faye |
EVP, Chief Medical Officer |
Attribution de RSU |
50,000 |
$1.06 |
$53K |
50,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi